It was reported that the combination of AKT inhibitors and chemotherapeutic drugs could synergistically triggers apoptosis and impedes tumor growth.[11] Capivasertib (CAP), a highly potent pan‐AKT kinase inhibitor, demonstrates a comparable inhibitory efficacy against three different subtypes of AKT. This evidence concerns the gene AKT1 and neoplasm.